AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

NEOGENOMICS INC Director's Dealing 2022

Jun 15, 2022

32227_dirs_2022-06-14_eb49e903-8319-42e8-afba-d8b4a7d63f52.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-06-10

Reporting Person: TETRAULT LYNN A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-10	Common Stock	A	15556	—	Acquired	54667	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-10	Stock Option (Right to Buy)	$8.1	A	13882	Acquired	2029-06-10	Common Stock (13882.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$11.6	2023-06-01	Common Stock (1507.0)	1507	Direct
Stock Option (Right to Buy)	$22.52	2026-06-06	Common Stock (2136.0)	2136	Direct
Stock Option (Right to Buy)	$28.54	2027-05-28	Common Stock (3448.0)	3448	Direct
Stock Option (Right to Buy)	$40.9	2028-06-02	Common Stock (3714.0)	3714	Direct
Stock Option (Right to Buy)	$41.76	2028-10-11	Common Stock (972.0)	972	Direct